News headlines about Global Medical REIT (NYSE:GMRE) have been trending somewhat positive on Thursday, according to Accern Sentiment. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Global Medical REIT earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave news stories about the company an impact score of 47.136514225694 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the news stories that may have impacted Accern’s analysis:
Several brokerages recently weighed in on GMRE. TheStreet cut Global Medical REIT from a “c-” rating to a “d” rating in a report on Thursday, February 1st. Zacks Investment Research upgraded Global Medical REIT from a “hold” rating to a “strong-buy” rating and set a $9.75 target price for the company in a report on Wednesday, May 9th. B. Riley dropped their target price on Global Medical REIT from $10.50 to $10.00 and set a “buy” rating for the company in a report on Thursday, May 10th. Finally, DA Davidson upgraded Global Medical REIT from a “neutral” rating to a “buy” rating and set a $8.00 target price for the company in a report on Wednesday, March 28th. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $10.05.
GMRE stock traded down $0.13 during trading on Thursday, hitting $8.43. 45,722 shares of the company traded hands, compared to its average volume of 146,888. The stock has a market capitalization of $184.94 million, a PE ratio of 15.61, a P/E/G ratio of 1.18 and a beta of 0.34. Global Medical REIT has a 1 year low of $8.54 and a 1 year high of $8.66. The company has a debt-to-equity ratio of 1.31, a current ratio of 0.17 and a quick ratio of 0.17.
Global Medical REIT (NYSE:GMRE) last issued its earnings results on Tuesday, May 8th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.02). The company had revenue of $11.56 million for the quarter, compared to analysts’ expectations of $11.50 million. Global Medical REIT had a net margin of 7.75% and a return on equity of 1.61%. analysts anticipate that Global Medical REIT will post 0.81 EPS for the current year.
In other Global Medical REIT news, Chairman Jeffrey Busch acquired 6,000 shares of the company’s stock in a transaction on Tuesday, March 13th. The stock was acquired at an average price of $7.13 per share, for a total transaction of $42,780.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 13.00% of the company’s stock.
Global Medical REIT Company Profile
Global Medical REIT Inc is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company's management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers.
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.